Structure of human lanthionine synthetase C-like protein 1 and its interaction with Eps8 and glutathione
- Wenchi Zhang1,6,
- Liang Wang2,6,
- Yijin Liu1,6,
- Jiwei Xu1,
- Guangyu Zhu3,
- Huaixing Cang1,
- Xuemei Li1,
- Mark Bartlam4,
- Kenneth Hensley5,7,
- Guangpu Li2,
- Zihe Rao1,4,8 and
- Xuejun C. Zhang1,3,9
- 1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China;
- 2Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA;
- 3Protein Studies Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, USA;
- 4College of Life Sciences and Tianjin Key Laboratory of Protein Science, Nankai University, Tianjin 300071, China;
- 5Free Radical Biology and Aging Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, USA
-
↵6 These authors contributed equally to this work.
Abstract
Eukaryotic lanthionine synthetase C-like protein 1 (LanCL1) is homologous to prokaryotic lanthionine cyclases, yet its biochemical functions remain elusive. We report the crystal structures of human LanCL1, both free of and complexed with glutathione, revealing glutathione binding to a zinc ion at the putative active site formed by conserved GxxG motifs. We also demonstrate by in vitro affinity analysis that LanCL1 binds specifically to the SH3 domain of a signaling protein, Eps8. Importantly, expression of LanCL1 mutants defective in Eps8 interaction inhibits nerve growth factor (NGF)-induced neurite outgrowth, providing evidence for the biological significance of this novel interaction in cellular signaling and differentiation.
Keywords
Footnotes
-
↵7 Present address: Department of Pathology, MS 1090, University of Toledo, Health Sciences Campus, 3000 Arlington Ave., Toledo, OH 43614, USA.
-
↵8 Corresponding authors.
E-MAIL raozh{at}xtal.tsinghua.edu.cn; FAX 86-10-62773145.
-
↵9 E-MAIL zhangc{at}omrf.org; FAX (405) 271-7543.
-
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1789209.
-
Supplemental material is available at http://www.genesdev.org.
-
- Received February 6, 2009.
- Accepted May 4, 2009.